Max Healthcare Institute Limited has informed the Exchange regarding a press release dated August 13, 2025, titled "Max Healthcare Q1 revenue soars to ₹ 2,574 Cr, registering growth of 27% YoY, Network Operating EBITDA grows to ₹ 613 Cr, +23% YoY; PAT grows by +17% YoY to ₹ 345 Cr".
MAXHEALTH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Max Healthcare reported strong Q1 FY26 results with gross revenue of ₹2,574 Cr, up 27% year-on-year, driven by a 26% jump in occupied bed days. Network Operating EBITDA grew 23% YoY to ₹613 Cr, though EBITDA margin compressed to 24.9% from 25.8% in Q1 FY25 and 27.2% in Q4 FY25. Profit after tax rose 17% YoY to ₹345 Cr. Free cash from operations stood at ₹389 Cr versus ₹258 Cr last year. International patient revenue surged 32% YoY to ₹208 Cr. Net debt increased to ₹1,755 Cr from ₹1,576 Cr as the company invested ₹435 Cr in expansion and ₹131 Cr for land purchase at Vaishali.
Strong top-line growth and continued capacity expansion (new Mohali tower trial runs, Dehradun hospital approval) signal robust demand, but margin compression and rising net debt may temper near-term enthusiasm. Shareholders benefit from consistent earnings growth and expansion pipeline adding ~2,600 beds over the next 4-5 years.